Multiple factor indices of protection or risk towards disease

被引:1
作者
Belfiore, F [1 ]
Iannello, S [1 ]
机构
[1] Univ Catania, Sch Med, Osped Garibaldi,Chair Internal Med, Inst Med Interna & Special Internist, I-95123 Catania, Italy
关键词
D O I
10.1054/mehy.2000.1141
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to combine several factors entailing protection or risk towards disease and to calculate a Protection Multiple Factor Index (PMFI) or, conversely, a Risk Multiple Factor Index (RMFI), we propose the following formulae: (1) PMFI = 2/[(mF)(2)+1] and (2) RMFI = 2/[(imF)2+1], where mF is the mean value of the factors considered and imF is the inverse (or reciprocal) of mF. In calculating mF, the value of each 'risk factor' observed in the patient under study (Vp) is expressed by taking the mean normal value (Vmn) as the unit, i.e. by calculating the ratio Vp/Vmn, whereas each 'protection factor' is expressed as the reciprocal of this ratio, i.e. as Vmn/Vp. The 'weight' of the various factors can be changed through multiplication by a number >1 or <1. Values of both PMFI and RMFI are always close to 1 in normal subjects, with extreme variations among patients between 0 and 2. The sum of the values of PMFI and RMF1 is always equal to 2, so that one index can be deduced from the other. When factors are only two (F1 and F2), the formulae may be simplified as follows: PMFI = 2/[F1 x F2)+1] and RMFI = 2/[(iF1 x iF2)+1], where if = 1/F, with only minimal changes in results. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:200 / 206
页数:7
相关论文
共 13 条
[1]  
[Anonymous], 1994, CIRCULATION
[2]   Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels [J].
Belfiore, F ;
Iannello, S ;
Volpicelli, G .
MOLECULAR GENETICS AND METABOLISM, 1998, 63 (02) :134-141
[3]   Insulin resistance in obesity: Metabolic mechanisms and measurement methods [J].
Belfiore, F ;
Iannello, S .
MOLECULAR GENETICS AND METABOLISM, 1998, 65 (02) :121-128
[4]  
BELFIORE F, 1995, DIABETOLOGIA, V38, pA126
[5]  
BELFIORE F, 1995, EUR J INTERN MED S1, V6, pA144
[6]   Association of the platelet PIA polymorphism of glycoprotein IIb/IIIa and the fibrinogen B beta 448 polymorphism with myocardial infarction and extent of coronary artery disease [J].
Carter, AM ;
OsseiGerning, N ;
Wilson, IJ ;
Grant, PJ .
CIRCULATION, 1997, 96 (05) :1424-1431
[7]   Ten-year follow-up results from the Goettingen risk, incidence and prevalence study (GRIPS) .1. Risk factors for myocardial infarction in a cohort of 5790 men [J].
Cremer, P ;
Nagel, D ;
Mann, H ;
Labrot, B ;
MullerBerninger, R ;
Elster, H ;
Seidel, D .
ATHEROSCLEROSIS, 1997, 129 (02) :221-230
[8]   Lipid composition of mononuclear cell membranes and serum from persons with high or low levels of serum HDL cholesterol [J].
Eggesbo, JB ;
Hagve, TA ;
Borsum, K ;
Hostmark, AT ;
Hjermann, I ;
Kierulf, P .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (03) :199-210
[9]   Relationship between plasma fibrinogen and coronary heart disease in women [J].
Eriksson, M ;
Egberg, N ;
Wamala, S ;
Orth-Gomér, K ;
Mittleman, MA ;
Schenck-Gustafsson, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) :67-72
[10]   Serum lipids and incidence of coronary heart disease - Findings from the systolic hypertension in the elderly program (SHEP) [J].
Frost, PH ;
Davis, BR ;
Burlando, AJ ;
Curb, JD ;
Guthrie, GP ;
Isaacsohn, JL ;
WassertheilSmoller, S ;
Wilson, AC ;
Stamler, J .
CIRCULATION, 1996, 94 (10) :2381-2388